Trial intelligence / Profile preview

Methylergometrine daily administration in puerperium

2010-019809-42Phase 4Active

Sponsor
University of Naples Federico II
Start
Jul 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in postpartum hemorrhage (PPH), anaemia and endometritis comparing Methylergometrine daily with Placebo (2 arms). Primary endpoint: Change in hemoglobin from delivery to day 10 postpartum. Started Jul 2010; status: active.

02

Drugs

methylergometrine
03

Conditions

postpartum hemorrhage (PPH)anaemiaendometritis

Beyond the preview

Go deeper on 2010-019809-42.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-019809-42.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call